Trial Profile
The influence of azelnidipine on plasma renin activity and plasma aldosterone concentration in hypertensive patients.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 03 Mar 2009
Price :
$35
*
At a glance
- Drugs Azelnidipine (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics
- 02 Mar 2009 New trial record.